• Please log in or register to access this feature.

Original Article

Direct renin inhibitor, aliskiren, attenuates the progression of non-alcoholic steatohepatitis in the rat model

  1. Yosuke Aihara,
  2. Hitoshi Yoshiji*,
  3. Ryuichi Noguchi,
  4. Kosuke Kaji,
  5. Tadashi Namisaki,
  6. Yusaku Shirai,
  7. Akitoshi Douhara,
  8. Kei Moriya,
  9. Hideto Kawaratani,
  10. Hiroshi Fukui

Article first published online: 28 FEB 2013

DOI: 10.1111/hepr.12081

Additional Information

How to Cite

Aihara, Y., Yoshiji, H., Noguchi, R., Kaji, K., Namisaki, T., Shirai, Y., Douhara, A., Moriya, K., Kawaratani, H. and Fukui, H. (2013), Direct renin inhibitor, aliskiren, attenuates the progression of non-alcoholic steatohepatitis in the rat model. Hepatology Research. doi: 10.1111/hepr.12081

Author Information

  1. Third Department of Internal Medicine, Nara Medical University, Nara, Japan

*Correspondence: Dr Hitoshi Yoshiji, The Third Department of Internal Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan. Email: yoshijih@naramed-u.ac.jp

  1. Disclosures: The authors have no conflict of interest and received no financial support for this manuscript.

Publication History

  1. Article first published online: 28 FEB 2013
  2. Accepted manuscript online: 29 JAN 2013 05:52AM EST
  3. Manuscript Accepted: 21 JAN 2013
  4. Manuscript Revised: 16 JAN 2013
  5. Manuscript Received: 13 SEP 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (553K)
FilenameFormatSizeDescription
hepr12081-sup-0001-FigureS1.tif8667K

Figure S1 Effect of DRI on CDAA-induced liver steatosis.

Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

View Full Article with Supporting Information (HTML) Get PDF (553K)